ARMP - יחס חוב להיוון בספרים Armata Pharmaceuticals Inc

As a clinical startup, Armata Pharmaceuticals (ARMP) adheres to basic environmental standards for laboratory waste disposal. The company minimizes scientific risks by creating unique agents against superbugs. This price chart on GURU.Markets reflects the asset's dynamics, with a value reaching 0.00. The business relies on the development of phage therapy for the hospital sector, focusing on the treatment of severe pulmonary pathogens.

This ratio reflects the relationship between total liabilities and equity, measuring the degree of financial leverage and the company's dependence on borrowed funds. Analyzing the current debt level relative to balance sheet equity allows for an assessment of the stability of Armata Pharmaceuticals (ARMP), where a diversified pipeline of bacteriophage drugs reduces investment risks, enabling the optimization of the liability structure when financing clinical trials.